Point-of-care Early Cancer Breath Testing

We are proud to be the first team to develop a cancer-specific breath marker and a POC breathalyzer device with high sensitivity and promising clinical applicability in detecting cancer tumors. Our clinical studies have demonstrated the detection of early stage 0–I microinvasive lung adenocarcinoma that screens out higher risk patients for prioritized follow up and better utilize the limited medical resources in the hospital. Also, real-time cancer treatment response monitoring that can flag progression ahead of imaging addition to how doctors monitor patients in routine practice.